Journal Information
Vol. 45. Issue S4.
EPOC y comorbilidad: una visión global
Pages 51-53 (March 2009)
Share
Share
Download PDF
More article options
Vol. 45. Issue S4.
EPOC y comorbilidad: una visión global
Pages 51-53 (March 2009)
Full text access
Ansiedad y EPOC
Anxiety and COPD
Visits
16530
Myriam Calle Rubio, Juan Luis Rodríguez Hermosa
Corresponding author
jlrhermosa@yahoo.es

Autor para correspondencia.
, María Jesús Gómez Nebreda
Servicio de Neumología, Hospital Clínico San Carlos, Universidad Complutense, Madrid, España
This item has received
Article information
Resumen

Los síntomas de ansiedad y depresión son frecuentes en los pacientes que padecen una enfermedad pulmonar obstructiva crónica (EPOC), pero son escasamente diagnosticados y hay pocos datos publicados sobre esta asociación. Su prevalencia varía considerablemente según los estudios, pero es probable que sea mayor de la conocida en la actualidad. Sólo un tercio de estos pacientes recibe un tratamiento adecuado. Algunos fármacos, el tratamiento conductual y la atención por un equipo multidisciplinario pueden mejorar el tratamiento de estos transtrornos en estos pacientes. Un buen ejemplo de ello es la rehabilitación respiratoria.

Palabras clave:
Ansiedad
Enfermedad pulmonar obstructiva crónica
Depresión
Abstract

Symptoms of anxiety and depression are common in patients with chronic obstructive pulmonary disease (COPD) but are underdiagnosed and data on this association are scarce. The prevalence of anxiety and depression in COPD varies considerably among studies and is probably greater than is currently known. Only a third of these patients receives appropriate treatment. Certain drugs, behavioral therapy and a multidisciplinary approach can improve the management of these patients, a good example being respiratory rehabilitation.

Keywords:
Anxiety
Chronic obstructive pulmonary disease
Depression
Full text is only aviable in PDF
Bibliografía
[1.]
B.R. Celli, W. MacNee.
Committee members standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.
Eur Respir J, 23 (2004), pp. 932-946
[2.]
A.G. Agusti.
COPD, a multicomponent disease: implications for management.
Respir Med, 99 (2005), pp. 670-682
[3.]
M.E. Kunik, K. Roundy, C. Veazey, J. Souchek, P. Richardson, N.P. Wray, et al.
Surprisingly high prevalence of anxiety and depression in chronic breathing disorders.
Chest, 127 (2005), pp. 1205-1211
[4.]
K. Hill, R. Geist, R.S. Goldstein, Y. Lacasse.
Anxiety and depression in end-stage COPD.
Eur Respir J, 31 (2008), pp. 667-677
[5.]
Y. Lacasse, L. Rousseau, F. Maltais.
Prevalence of depressive symptoms and depression in patients with severe oxygendependent chronic obstructive pulmonary disease.
J Cardiopulm Rehabil, 21 (2001), pp. 80-86
[6.]
Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. A clinical trial. Ann Intern Med. 1983;99:612-20.
[7.]
Nocturnal Oxygen Therapy Trial Group.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial.
Ann Intern Med, 93 (1980), pp. 391-398
[8.]
A.M. Yohannes, R.C. Baldwin, M.J. Connolly.
Prevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary disease.
Int J Geriatr Psychiatr, 18 (2003), pp. 412-416
[9.]
G. Garuti, C. Cilione, D. Dell’Orso, P. Gorini, M.C. Lorenzi, L. Totaro, et al.
Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients.
Monaldi Arch Chest Dis, 59 (2003), pp. 56-61
[10.]
J. Maurer, V. Rebbapragada, S. Borson, R. Goldstein, M.E. Kunik, A.M. Yohannes, et al.
Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.
Chest, 134 (2008), pp. 43S-56S
[11.]
A.M. Yohannes, R.C. Baldwin, M.J. Connolly.
Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease.
Age Ageing, 34 (2005), pp. 491-496
[12.]
A.T. Beck, N. Epstein, G. Brown, R.A. Steer.
An inventory for measuring clinical anxiety: psychometric properties.
J Consult Clin Psychol, 56 (1988), pp. 893-897
[13.]
V.S. Fan, S.D. Ramsey, N.D. Giardino, B.J. Make, C.F. Emery, P.T. Diaz, et al.
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease.
Arch Intern Med, 167 (2007), pp. 2345-2353
[14.]
S. Borson, G.J. McDonald, T. Gayle, M. Deffebach, S. Lakshminarayan, C. VanTuinen.
Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.
Psychosomatics, 33 (1992), pp. 190-201
[15.]
P. Argyropoulou, D. Patakas, A. Koukou, P. Vasiliadis, D. Georgopoulos.
Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease.
Respiration, 60 (1993), pp. 216-220
[16.]
C.F. Emery, R.L. Schein, E.R. Hauck, N.R. MacIntyre.
Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease.
Health Psychol, 17 (1998), pp. 232-240
[17.]
American College of Chest Physicians and American Association of Cardiovascular and Pulmonary Rehabilitation.
Pulmonary rehabilitation: joint ACCP/AACVPR evidence- based clinical practice guidelines.
Chest, 131 (2007), pp. 4s-42s
Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?